Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1991 | 12-1990 | 12-1989 | 12-1988 | |
| Cash Flows From Operating Activities | ||||
| Net Income | 3,520 | 956 | 682 | 682 |
| Depreciation Amortization | 4,200 | 1,989 | 1,313 | 1,313 |
| Other Working Capital | N/A | 4,888 | -1,677 | -1,677 |
| Other Operating Activity | 3,010 | 113 | 143 | 143 |
| Operating Cash Flow | $10,730 | $7,946 | $461 | $461 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | N/A | -4,006 | -2,836 | -2,836 |
| Net Acquisitions | N/A | -6,963 | N/A | N/A |
| Other Investing Activity | -4,410 | -311 | 0 | 0 |
| Investing Cash Flow | $-4,410 | $-11,280 | $-2,836 | $-2,836 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | -620 | -408 | -379 | -379 |
| Financing Cash Flow | $-620 | $-408 | $-379 | $-379 |
| Exchange Rate Effect | -3 | 227 | -161 | -161 |
| Beginning Cash Position | 5,050 | 8,572 | 11,487 | 11,487 |
| End Cash Position | 10,750 | 5,057 | 8,572 | 8,572 |
| Net Cash Flow | $5,690 | $-3,515 | $-2,915 | $-2,915 |
| Free Cash Flow | ||||
| Operating Cash Flow | 10,730 | 7,946 | 461 | 461 |
| Free Cash Flow | 10,730 | 7,946 | 461 | 461 |